BCX 150 Pill - blue & white capsule/oblong, 19mm
Generic Name: berotralstat
Pill with imprint BCX 150 is Blue & White, Capsule/Oblong and has been identified as Orladeyo 150 mg. It is supplied by BioCryst Pharmaceuticals, Inc.
Orladeyo is used in the treatment of Hereditary Angioedema and belongs to the drug class hereditary angioedema agents. Orladeyo 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BCX 150
Orladeyo
- Generic Name
- berotralstat
- Imprint
- BCX 150
- Strength
- 150 mg
- Color
- Blue & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Hereditary angioedema agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BioCryst Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 72769-0101
See also:
Takhzyro
Takhzyro (lanadelumab-flyo) is used to prevent hereditary angioedema (HAE) and reduce symptoms ...
Berinert
Berinert is used to treat acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Andembry
Andembry is used to prevent attacks of Hereditary Angioedema (HAE) in adults and children 12 years ...
Ruconest
Ruconest is used to treat angioedema attacks in adult and adolescent patients with Hereditary ...
Firazyr
Firazyr is used for hereditary angioedema (HAE) to treat acute HAE attacks in adults 18 years and ...
Haegarda
Haegarda is an injectable protein replacement therapy that prevents swelling and attacks in ...
Kalbitor
Kalbitor injection is used to treat acute attacks of hereditary angioedema (HAE) in patients 12 ...
Cinryze
Cinryze (complement C1 esterase inhibitor) is used to prevent attacks of angioedema in people with ...
Lanadelumab
Lanadelumab injection is a monoclonal antibody used to prevent hereditary angioedema. Includes side ...
More about Orladeyo (berotralstat)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.